Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 31 March 2024
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
63
Renminbi (CNY)
13
Euro (EUR)
13
Indian rupee (INR)
5
Swiss franc (CHF)
3
Other currencies (CAD, DKK, GBP, HDK, SEK)
3
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
35
Public (from private) companies
22
Public companies
20
Funds
10
Cash and cash equivalents
11
Other assets
2
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
38
Products on the market
25
Preclinical
8
Phase I
9
Phase II
16
Phase III
4
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
26
Oncology
19
Central nervous system
12
Synthetic biology
13
Digital Health
9
Orphan diseases
8
Immunology/Inflammation
7
Medical technology / diagnostics
6
#d997b6
#cc5d3f
#60504c
#49753d
#b7d4d8
#cab415
#423e3d
#3880c0
#ad2d3c
#94743a